New York, NY – Dr. Borer is a cardiologist and Professor of Medicine, Cell Biology, Radiology, Surgery and Public Health at the State University of New York Downstate Medical University and Schools of Medicine and Public Health.
Rated in the Top 1 Percent Physicians by U.S. News & World Report LP in Cardiology, Dr. Borer first was nationally and internationally acclaimed for his work in establishing the benefits of nitroglycerin during heart attacks. Later, he was instrumental in the development of real-time radionuclide cineangiography and its application during exercise. This development profoundly changed the way cardiology was practiced.
Dr. Borer’s career has taken him from Brooklyn, where he was raised, to Harvard College (where he majored in Government) to Cornell Medical College for his MD, to the Massachusetts General Hospital for training in internal medicine, to the National Institute of Health for training and research in Cardiology, to London as a Senior Fulbright-Hays Scholar at Guy’s Hospital (University of London), back to Cornell as Gladys and Roland Harriman Professor of Cardiovascular Medicine, to SUNY Downstate as Chief of Cardiology and Chairman of Medicine. Since 2008, he has also served as the chairman of The Howard Gilman Institute for Heart Valve Disease and of the Schiavone Cardiovascular Translational Research Institute at SUNY Downstate Medical University.
Dr. Borer’s most recent investigations center on prognostication strategies in patients with heart valve diseases and evaluation of drugs and devices for heart failure.
“Real doctors learn how to solve problems,” says Dr. Borer. “Your education doesn't stop when you finish school.”
For more information, visit www.drjeffreysborer.com